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Background: The intracellular carrier protein(s) for monoacylglycerols (MGs) is unknown.
Results: Using chromatography and NMR and fluorescence spectroscopy, we show that liver fatty acid-binding protein
(LFABP) is a binding protein for MG and promotes rapid MG transfer to membranes.
Conclusion: LFABP binds MG in vitro and in liver cytosol.
Significance: LFABP may transport MG, a metabolic intermediate and signaling molecule, in liver and intestinal cytosol.
Liver fatty acid-binding protein (LFABP; FABP1) is expressed
both in liver and intestinal mucosa. Mice null for LFABP were
recently shown to have altered metabolism of not only fatty
acids but also monoacylglycerol, the two major products of die-
tary triacylglycerol hydrolysis (Lagakos, W. S., Gajda, A. M.,
Agellon, L., Binas, B., Choi, V., Mandap, B., Russnak, T., Zhou,
Y. X., and Storch, J. (2011) Am. J. Physiol. Gastrointest. Liver
Physiol. 300, G803–G814). Nevertheless, the binding and trans-
port of monoacylglycerol (MG) by LFABP are uncertain, with
conflicting reports in the literature as to whether this single
chain amphiphile is in fact bound by LFABP. In the present
studies, gel filtration chromatography of liver cytosol from
LFABP2/2mice shows the absence of the lowmolecular weight
peak of radiolabeled monoolein present in the fractions that
contain LFABP in cytosol from wild type mice, indicating that
LFABP binds sn-2 MG in vivo. Furthermore, solution-state
NMR spectroscopy demonstrates twomolecules of sn-2monoo-
lein bound in the LFABP binding pocket in positions similar to
those found for oleate binding. Equilibrium binding affinities
are ;2-fold lower for MG compared with fatty acid. Finally,
kinetic studies examining the transfer of a fluorescent MG ana-
log show that the rate of transfer of MG is 7-fold faster from
LFABP to phospholipid membranes than from membranes to
membranes and occurs by an aqueous diffusion mechanism.
These results provide strong support for monoacylglycerol as a
physiological ligand for LFABP and further suggest that LFABP
functions in the efficient intracellular transport of MG.
In the intestine, dietary triacylglycerol digestion generates
large quantities of fatty acids (FAs)5 and sn-2 monoacylglycer-
ols (MGs), which are then taken up by absorptive enterocytes
and used primarily for triacylglycerol resynthesis in the endo-
plasmic reticulum (1, 2). In recent years, it has become appre-
ciated that MGsmay be important not only as intermediates in
TG synthesis and degradation but also for other reasons. In
particular, 2-arachidonoylglycerol has attracted much atten-
tion as an endogenous cannabinoid receptor ligand (3, 4). In the
intestine, 2-arachidonoylglycerol may play a role in regulating
motility and incretin hormone secretion among other proper-
ties (5–9).
We reported previously that long chain MGs and FAs are
taken up into the enterocyte at least in part via a common pro-
tein-mediated pathway (10, 11).Once inside the cell, both lipids
must move to intracellular organelles for metabolic processing.
Liver fatty acid-binding protein (LFABP; FABP1) is expressed
abundantly in the small intestinal mucosa as well as in the hep-
atocyte. Although it is clear that LFABP binds long chain FAs
and likely serves as an intracellular FA transport protein (12,
13), the intracellular transport ofMGhas been little considered.
In mice null for LFABP, we recently showed that intestinal MG
metabolism is significantly perturbed but that the changes in
MG metabolism are not due to changes in expression of genes
related to MG and TG metabolism (14). These results suggest
an MG trafficking defect in the LFABP2/2 mice; however, a
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controversy exists as to whether LFABP binds MG. Using a
fluorescence displacement assay, it was concluded thatmonoo-
lein does not bind to LFABP (15), whereas other studies showed
binding of a fluorescent monoolein analog to LFABP and
quenching of the intrinsic tyrosine fluorescence of LFABP by
monoolein addition (16), suggesting that MG does bind to
LFABP. To understand the basic mechanism of intracellular
MG transport as well as the mechanism underlying the effects
of LFABP gene ablation on intestinal MG metabolism, it is
important to determine unequivocally whether or not mono-
acylglycerol is a ligand for LFABP.
In the present studies, we used chromatographic analysis of
liver cytosol from wild type and LFABP-null mice, equilibrium
binding studies, structural perturbation of LFABP monitored
by NMR spectroscopy, and transfer kinetics of a fluorescent
monoolein analog to demonstrate that MG binds to LFABP
both in vitro and in vivo and can serve to efficiently transferMG
to acceptor membranes. The results resolve the controversy
and provide strong support for a role for LFABP as an intracel-
lular MG transport protein.
EXPERIMENTAL PROCEDURES
Materials—Rat LFABP was purified as described previously
(17). [14C]Oleic acid ([1-14C]oleic acid; 54 mCi/mmol) was
obtained fromPerkinElmer Life Sciences. [3H]Monoolein (sn-2
[9,10-3H]monoolein; 40–60 Ci/mmol) was from American
Radiolabeled Chemicals (St. Louis, MO). Quinine sulfate and
antibodies to human albumin were obtained from Sigma-Al-
drich. U-15N-enriched recombinant rat LFABP was expressed
in Escherichia coli in 15NH4Cl minimal medium as described
previously (18, 19). Antibodies to purified rat LFABPwere gen-
erated in rabbits by Affinity Bioreagents (Golden, CO) (14).
12-(9-Anthroyloxy)oleic acid (12AO) was from Molecular
Probes, Inc. (Eugene, OR). Unlabeled sodium oleate and sn-1
monoolein were obtained from Sigma. Unlabeled sn-2 monoo-
lein was obtained from Doosan Serdary Research Laboratories
(Toronto, Canada). The fluorescentMG analog 12-(9-anthroy-
loxy)oleoyl-sn-1-glycerol (MG12AO) was synthesized by con-
densation of 12AO with glycerol 1,2-isopropylidene ketal
(Molecular Probes, Inc.), and the structure was verified by
NMR spectroscopy as reported previously (20). Egg phosphati-
dylcholine (EPC) and N-(7-nitro-2,1,3-benzoxadiazol-4-yl)
phosphatidylethanolamine (NBD-PE) were obtained from
Avanti Polar Lipids (Birmingham,AL). All othermaterials were
reagent grade or better.
Animals and Tissue Harvest—Liver tissue was harvested
from male C57BL6/J wild type and congenic LFABP2/2 mice
(14) following perfusion via the inferior vena cava with phos-
phate-buffered saline, pH 7.4 (PBS) and homogenized with a
Potter-Elvehjemhomogenizer in PBSwith 0.5% protease inhib-
itor mixture (Sigma 8340) on ice. The homogenate was centri-
fuged at 600 3 g for 10 min at 4 °C, and the supernatant was
further centrifuged at 105,0003 g for 90min at 4 °C to obtain a
cytosol fraction. Protein concentration was determined by the
Bradford method (21).
Cytosolic FA andMGBinding—Cytosolic lipid binding capa-
bility was assessed as described by Martin et al. (22). In brief, a
1.53 30-cm Superdex G75 column was equilibrated with PBS
and calibrated with a molecular mass kit (Sigma) including
aprotinin (6.5 kDa), cytochrome c (12.4 kDa), carbonic anhy-
drase (29 kDa), and albumin (66 kDa). 10 mg of cytosol protein
in 250 ml of PBS was incubated with 5 mCi of [14C]oleate or 5
mCi of [3H]monoolein for 10 min at 25 °C and loaded onto the
column. Fractions were eluted with PBS at 1 ml/min, and the
protein concentration of the eluent was monitored continu-
ously by spectrophotometry (labs, 280 nm). 2-ml fractions were
collected on ice. 10-ml aliquots were used for scintillation
counting. Fractions were concentrated to 0.5 ml using Amicon
centrifugal filter units (10,000 molecular weight cutoff).
Immunoblotting—35ml of concentrated fractions and 3mg of
purified LFABP were loaded onto 15% polyacrylamide gels and
separated by SDS-PAGE. The proteins were transferred to a
0.45-mm nitrocellulose membrane using a Semi-Dry transfer
system (Bio-Rad) for 1 h 20 min at 20 V. The membranes were
incubated in a 5% nonfat dry milk blocking solution overnight
at 4 °C and then washed with two 5-min rinses and one 15-min
rinse with wash buffer (0.05 M Tris-HCl, 0.15 M NaCl, 0.1%
Tween 20, pH 7.6). Membranes were then incubated with the
anti-rat LFABP antibody (14) at 1:5,000 in PBS for 1.5 h at room
temperature. Followingwashing as above, themembranes were
incubated with the secondary antibody (rat anti-rabbit IgG;
1:10,000) for 1 h and then visualized by chemiluminescence
(ECL reagent, GE Healthcare).
Ligand Binding Affinities—The binding affinities of oleate
and monoolein to purified LFABP were estimated using the
Lipidex 1000 assay as described by Glatz and Veerkamp (23).
Briefly, 10 mM Tris-HCl buffer, pH 8.0 was used to dilute oleic
acid, monooleoylglycerol, and LFABP stock solutions.
[14C]Oleic acid dilutions from 1 to 10 mM were freshly
prepared from an ethanolic stock solution ([1-14C]oleic acid;
54.4 mCi/mmol; 250 mCi in ethanol; PerkinElmer Life Sci-
ences). [3H]Monooleoylglycerol dilutions from 1 to 10mMwere
freshly prepared by adding 0.5mCi of [3H]monooleoylglycerol
(2-monooleoyl[9,10-3H]glycerol; 60 Ci/mmol; 250 mCi in ace-
tonitrile; American Radiolabeled Chemicals) to 4 ml of a 10 mM
solution of 2-monooleoylglycerol (C18:1, cis-9, Sigma). For the
binding assay, 150 ml of buffer, 50 ml of LFABP solution (2.72
mM), and 50 ml of ligand solution were mixed in this order in a
1.5-ml Eppendorf polypropylene reaction vial. After incubation
for 15 min at 37 °C, vials were centrifuged for 5 s and placed on
ice. From each vial, 50 ml was used for scintillation counting to
determine the ligand concentration in the aqueous solution. To
the remaining 200 ml, 50 ml of continuously stirred ice-cold
Lipidex 1000 suspension (Sigma) was added andmixed three to
four times on a Vortex mixer during a 30-min incubation
period at 0 °C. Finally, the vials were centrifuged (2 min at
10,0003 g at 4 °C), and 100ml of supernatantwas transferred to
a scintillation vial and used to quantify the amount of bound
ligand. Radioactivitywasmeasuredwith a PerkinElmerWallace
1409 DSA liquid scintillation counter (PerkinElmer Life Sci-
ences). Blank values obtained for each ligand dilution by mea-
suring the radioactivity of incubations in which 50 ml of buffer
without LFABPwas addedwere subtracted.Datawere analyzed
using the Hill equation (x/(n 2 x)) 5 c log[ligand]i 1 log K9
where x is ligand bound/total LFABP, n is the number of bind-
ing sites, and c is the Hill coefficient.
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Preparation of NMRSamples—A0.40mM solution of U-15N-
enriched apo-LFABP was prepared in 10 mM NaH2PO4, 250
mMNaCl, 5mM EDTA, 0.02%NaN3, and 5%D2O at pH 6.0. For
titration of LFABP with oleic acid (OA), 1.8-ml aliquots of 100
mM sodium oleate were added successively to 579 ml of the
apoprotein, corresponding to complexes of [15N]LFABP with
protein-to-ligand molar ratios of 1:0.4, 1:0.8, 1:1.2, 1:1.6, 1:2.0,
and 1:3.0, respectively, as used in a prior set of experiments (24).
For titration of LFABP with monoolein, a stock solution con-
taining 17.1mg of themonoglyceride in hexanes was dried with
a stream of nitrogen for 30min in a small glass vial. Then 600ml
of 0.4 mM LFABP was added to obtain a 1:0.2 protein-ligand
complex. This solution was added to another 17.1 mg of MG
film in a different glass vial to form a 1:0.4 protein-ligand com-
plex and so on to obtain molar ratios of 1:0.6, 1:0.8, 1:1.0, 1:1.2,
1: 1.4, 1: 1.6, 1:1.8, and 1:2.0.
NMR Experiments and Analysis—The NMR spectra were
acquired on a VNMRS 600 Varian/Agilent spectrometer
equipped with a Nalorac 1H-optimized four-nucleus gradient
probe and operating at 599.761 MHz. Two-dimensional
1H-15N heteronuclear single quantum correlation NMR spec-
troscopy data (25) were recorded with 512 3 128 complex
points and 16 transients; measurements were made at 37 °C.
The 1H carrier frequency was set at the water peak (referenced
to 4.629 ppm at 37 °C), and the 15N carrier frequency was set in
the middle of the amide region (119.44 ppm). Chemical shifts
were referenced following the guidelines of Wishart and Sykes
(26). Two-dimensional data were processed with NMRPipe
software (27) and analyzed with NMRViewJ (28).
Assignments for 89.8% of the amino acid residues in the apo-
proteinwere taken fromHe et al. (24). The titrationsweremon-
itored by following the chemical shift changes in 1H-15N het-
eronuclear single quantum correlation spectra of the protein
upon addition of OA or MG ligands. Chemical shift perturba-
tions for each backbone cross-peak were calculated with the
following equation: DHN-N5 {[dHN(apo)2 dHN(complex)]21
[(dN(apo)2 dN(complex))/6.5]2}1/2 (29).
Vesicle Preparation—Small unilamellar vesicles (SUVs) were
prepared from 90 mol % EPC and 10% NBD-PE as described
(30). The phospholipid concentration of the vesicles was deter-
mined by quantification of inorganic phosphate (31).
Fluorescence Measurements—Fluorescence spectra were
obtained with an SLM 8000C fluorescence spectrophotometer.
Measurements were carried out at 24 °C in 3 3 3-mm micro-
cuvettes containing;0.3 ml of sample. Excitation wavelengths
were set at 383 nm for 12AO and MG12AO and 352 nm for
quinine sulfate. The fluorescence quantum yields (Q) for both
probes bound to LFABP as well as to EPC SUVs were deter-
mined relative to quinine sulfate in 0.1 N sulfuric acid. Spectra
were corrected for lamp and photomultiplier variation with
wavelength (32). The value of Q for the quinine sulfate refer-
ence was 0.7 (33).
Transfer of 12AO and MG12AO from LFABP to SUVs—The
transfer of 12AO andMG12AO from LFABP to acceptor SUVs
and analysis of the resulting data were conducted as described
previously (34–36). Briefly, LFABP was incubated with 12AO
or MG12AO for ;15 min at room temperature. A volume of
this donor complex was then mixed with an equal volume of
acceptor SUVs containing 10 mol % NBD-PE using an Applied
Photophysics SX17MV temperature-controlled stopped flow
spectrometer (Applied Photophysics Ltd., UK). The NBDmoi-
ety is an energy transfer quencher of the AO fluorescence (34).
Because 12AO and MG12AO bound to LFABP are fluorescent,
the rate of 12AOorMG12AO transfer from LFABP to quencher-
containingSUVswasmonitoreddirectlyby thedecrease in fluo-
rescence intensity over time following mixing. Except where
noted, the final transfer assaymixture contained 6mMLFABP, 1
mM 12AO or MG12AO, and 360 mM acceptor SUVs; transfer
was monitored at 24 °C. The standard assay buffer was Tris-
buffered saline (40 mM Tris-HCl, 100 mM NaCl, pH 7.4). Tris
buffer was used for studies from pH 6 to 9, and acetate buffer
was used for studies at pH 5. Software provided with the instru-
ment was used to analyze the transfer curves. The curves for
12AO andMG12AO transfer from LFABP to EPC membranes
were best fit by a single exponential function, and the curves for
intermembrane transfer were best fit by a double exponential
function in agreement with previous work (20, 34). For each
experimental condition, 5–10 replicates were done to derive
average transfer rates. Results aremean6 S.D. from at least five
separate experiments.
RESULTS
Reduced FA and MG Binding in LFABP2/2 Liver Cytosol—
The elution profiles of [14C]oleate and [3H]monoolein in liver
cytosol fromwild type and LFABP2/2mice are shown in Fig. 1.
In WT cytosol, fractions containing high [14C]oleate (Fig. 1A)
contained LFABP as shown by immunoblotting (Fig. 1E) and in
agreement with the results ofMartin et al. (22). By contrast and
again in agreement withMartin et al. (22), the [14C]oleate peak
is entirely absent from the corresponding fractions from
LFABP2/2 cytosol (Fig. 1B), and immunoblotting showed no
LFABP in those fractions as expected (Fig. 1E). These results
confirm that LFABP is the major binding protein for oleate in
liver cytosol. The small radioactivity peaks at higher molecular
weight are likely due to albumin, which was not removed by
liver perfusion. It is worth noting that in the intact hepatocyte
albumin is present in the secretory vesicle system, not as a cyto-
solic protein.
As shown in Fig. 1C, inWT cytosol, [3H]monoolein eluted in
fractions shown by immunoblotting to contain LFABP (Fig.
1F), andneither the radioactivity peak (Fig. 1D) nor LFABP (Fig.
1F) was present in the corresponding fractions fromLFABP2/2
cytosol. In the LFABP2/2 cytosol fractionation, a peak of
[3H]monooleinwas also found in a fraction containing peptides
of,6.5-kDa molecular mass. It is likely that in the absence of a
binding protein monoacylglycerols form micelles, which elute
at a low apparent molecular weight. The slight discordance
between the peaks of [3H]monoolein radioactivity andWestern
blot density could be due to small variations in sample concen-
tration,Western blot transfer, and/or immunodetection. Alter-
natively, the high specific activity of the [3H]monoolein used,
resulting in low levels of added ligand, may mean that the
LFABP detected by Western blot represents a combination of
LFABPbound to labeledMGplus LFABPbound to endogenous
ligand. Overall, the results demonstrate that in the liver LFABP
is themajor intracellular binding protein formonoacylglycerol.
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Equilibrium Binding Analysis—Lipidex binding analysis (23)
was used to estimate the oleate and monoolein binding affini-
ties for LFABP. Titrations with both ligands appeared sigmoidal
with Hill coefficients (the slope of the Hill plot at log(x/(n2 x))5
0) close to 2, suggesting positive binding cooperativity, a result
consistent with our previous studies of sequential fatty acid bind-
ing to two binding sites (18, 37). The apparent dissociation con-
stants, K9, obtained for both ligands using the Hill equation are
34.1 6 10.4 nM (n 5 5) for oleate and 63.4 6 7.8 nM (n 5 6) for
monoolein (p , 0.005). Because the LFABP tertiary structures
show that the two ligand binding sites are not equivalent, we also
approximated the dissociation constants for each site. To obtain a
value of Kd1, an extrapolation of the curve from high ligand con-
centrationswasperformed, and toobtain a valueofKd2, an extrap-
olation of the curve from low ligand concentrations was used. For
oleate binding, theKd1 andKd2 values obtainedwere 0.86 0.5 and
42.26 10.2 nM, respectively; for monoolein binding, Kd1 and Kd2
values were 2.7 6 1.1 nM (p , 0.05 compared with oleate) and
96.7 6 21.4 nM (p , 0.001 compared with oleate), respectively.
Representative analyses for each ligand are shown in Fig. 2.
FIGURE 1. [14C]Oleate and [3H]monoolein retention by WT and LFABP2/2 liver cytosol. Representative chromatograms of 10 mg of WT and LFABP2/2
cytosol (A280; hollow symbols) and [
14C]oleate (A and B) or [3H]monoolein (C and D) radioactivity (dpm; solid symbols) plotted against elution volume (ml) are
shown. Separate columns were packed for the two [14C]oleate and the two [3H]monoolein fractionations. 50 ml of concentrated fraction volume was probed
for LFABP inmultiple fractions fromeachof the runs; LFABP immunoblots are shown in E–H. The fractions are labeledby their elution volumes, and the first lane
in each immunoblot is the positive control 3 mg of purified LFABP.
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Monoolein Titration of LFABP Monitored by NMR
Spectroscopy—The binding of MG (monoolein) to LFABP in a
two-step fashion similar to OA (24) was demonstrated by using
two-dimensionalNMR spectroscopy tomonitor titration of the
protein with this ligand. Particular protein NH backbone sites
exhibited chemical shift perturbations (Dd) due to changes in
magnetic environment associatedwith ligand binding as shown
in the 1H-15N correlation spectra of Fig. 3. Some of the affected
sites showed contrasting behavior in terms of whether the envi-
ronmental perturbation occurred principally at the early titra-
tion stages (e.g. Phe-18, 0.6–0.8 eq ofMG) or at later stages (e.g.
Ile-29, 1.0–1.2 eq of MG). A perturbation analysis of the full
polypeptide chain (summarized graphically in Fig. 4) showed
that residues Ser-11, Phe-18, Glu-72, Gly-106, and Lys-121 (at
FIGURE 2. FAandMGbinding to LFABP. The Lipidex assaywas used to estimate equilibriumbinding affinities as described under “Experimental Procedures.”
Representative plots of sigmoidal curves of ligand concentration (mM) versus ligand bound (cpm) are shown (A and B). Dissociation constants for each binding
site were estimated by extrapolation of the curve from high ligand concentrations (to obtain Kd1) and by extrapolation of the curve from low ligand concen-
trations (for Kd2).
FIGURE 3. Representative expanded regions of the 1H-15N heteronuclear single quantum correlation NMR contour plots for wild-type LFABP moni-
tored during the ligand titration as the protein-to-MG ratio varies from 1:0 to 1:2. The chemical shift of residue Phe-18 is perturbedmainly from 0 to 0.8
eq of added MG (upper panels), whereas residue Ile-29 is perturbed mainly from 0.8 to 2.0 eq of added MG (lower panel). The positions of the apo- and
holoprotein forms are indicated by black and red crosshairs, respectively.
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internal locations within the protein cavity) were affected ini-
tially upon ligand addition, whereas Ile-29, Lys-33, Ile-35, and
Tyr-120 (at aqueous solution-accessible helical locations near
the protein portal) were perturbed predominantly at later
stages of MG addition. The broadening of these polypeptide
backbone resonances observed during this titration, which was
not evident in the analogous OA-LFABP experiments (24), is
indicative of two or more differently ligated protein forms with
intermediate exchange rates (k; Dd).
Monoolein Locations in the LFABP Complex from Solution-
state NMR Spectroscopy—The environmentally perturbed
LFABP residues listed above were mapped onto the oleate-
bound structure derived by solution-state NMR methods (18),
forming a roughly contiguous interface that defines the likely
locus of monoolein binding sites and argues against an inter-
pretation involving global protein conformational changes
(data not shown). Moreover, all residues affected by MG were
also perturbed during the analogous OA titration (24), suggest-
ingmonoglyceride locations in accordwith the structures of the
protein-FA complex solved in crystals (38) and in solution (18).
Specifically, binding of the first MG or OA ligand altered the
magnetic environment of Gly-106, Lys-121, and Glu-72/Thr-
73, whereas binding of the second MG or OA ligand affected
Ile-29, Lys-33, Ile-35, and Tyr-120. Additionally, the first MG
ligandperturbed Ser-11 andPhe-18, an observation thatmay be
attributed to the larger glycerol headgroup as compared with
the OA carboxyl and to a partially extended rather than
U-shaped conformation for the first ligand (Fig. 5).
Fluorescence Properties of 12AO and MG12AO with LFABP—
The fluorescence emission maxima of both LFABP-bound
MG12AO and LFABP-bound 12AO were considerably blue-
shifted (441 and 438 nm, respectively) with respect to emission
of membrane-bound MG12AO (449 nm) and membrane-
bound 12AO (451 nm) (Fig. 6). This result suggests a similarly
high degree of motional constraint for protein-bound
MG12AO and protein-bound 12AO (39). Table 1 shows the
fluorescent Q values for 12AO or MG12AO in LFABP com-
pared with EPC vesicles. The Q for MG12AO in EPC SUVs is
lower than that of 12AO in EPC SUVs, suggesting that the AO
moiety of MG12AO may penetrate less deeply in EPC SUV
membranes than the AOmoiety of the 12AO fatty acid analog.
The results also show that when bound to LFABP quantum
yields for MG12AO and 12AO are virtually identical. Collec-
tively, these results demonstrate that MG12AO and 12AO are
bound to LFABP in a similar manner. Both probes appear to
experience a highly hydrophobic binding site in which the
motion of the fatty acid chain is restricted.
12AO and MG12AO Transfer from LFABP to Small Unila-
mellar Vesicles—As shown in Fig. 7A, the rate of transfer of
MG12AO from LFABP to EPC SUVs is very similar to that of
12AO; transfer rates were 0.0276 0.002 and 0.0286 0.003 s21
for 12AO and MG12AO, respectively. In distinct contrast, the
rate ofMG12AO transfer fromSUV to SUV (0.0046 0.001 s21)
is 7-fold slower than that of 12AO (0.0296 0.002 s21) (Fig. 7B).
In previous studies, it was shown that the transfer of fluores-
cently labeled FA from LFABP to SUVs occurs via diffusion
through the aqueous phase (40, 41). To examine the mecha-
nismof transfer ofMG12AO fromLFABP to SUVs, the transfer
ratewas determined for a constant donor LFABPconcentration
and varying concentrations of acceptor vesicles. As shown in
Fig. 8, upon increasing the concentration of SUV acceptors, no
change in the transfer rate of either 12AO or MG12AO from
FIGURE 4. Composite 1H-15N chemical shift perturbation of wild-type
LFABPbackboneatomsby2.0eqofmonooleinplottedalongtheprotein
sequence and with respect to a-helical and b-strand secondary struc-
tural elements. Perturbations are calculated for instance as D(apo 2 holo)
(ppm) 5 {[dHN(apo) 2 dHN(complex)]
2 1 [(dN(apo) 2 dN(complex))/6.5]
2}1/2
(29). The dashed line at 0.15 ppm, set slightly below the mean6 S.D. of per-
turbations for thepair of protein forms, serves as aguide to identify backbone
sites with structurally significant chemical shift changes (highlighted in red).
Backbone sites that showsignificant chemical shift perturbations forbothMG
and OA ligands are designated by asterisks (*) along the residue number axis.
FIGURE 5. Monoolein and oleate locations within the wild-type LFABP
protein cavity. a, monoolein locations consistent with observed chemical
shift perturbations upon titration of LFABPwith 2 eq of ligand. b. oleate loca-
tions determined from lowest energy solution structures of the 2:1 complex
with LFABP in solution (18). c, residues perturbed by the first MG ligand to
enter. d, residues perturbed by the second MG ligand.
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LFABP to SUVs was observed, suggesting that the transfer of
both fatty acid and monoacylglycerol analogs from LFABP to
SUVs occurs by a similar aqueous diffusion mechanism.
To further evaluate the influence of aqueous MG solubility
on its rate of transfer from LFABP to SUVs, the effect of ionic
strength was examined. Increasing the NaCl concentration of
the buffer from 0.1 to 2 M caused a logarithmic decrease in the
rate of MG12AO transfer from LFABP to SUVs (Fig. 9). The
highest NaCl concentration (2 M) decreased the transfer rate by
4-fold comparedwith physiologic ionic strength.As shownpre-
viously, no major alterations in LFABP structure are caused by
these NaCl levels (40). This result is virtually identical to what
we found previously for 12AO transfer from LFABP to SUVs
(40), further suggesting that aqueous solubility directly influ-
ences the MG transfer rate.
The thermodynamic parameters describing 12AO and
MG12AOdissociation from LFABPwere studied by examining
the temperature dependence of the rate of 12AOandMG12AO
FIGURE 6. Emission spectra for 1mM 12AO (A) or MG12AO (B) bound to 5
mM LFABP (solid line) or to 0.1 mM EPC SUVs (dotted line) at pH 7.4.Mea-
surements were carried out at 24 °C. The excitation wavelength was 383 nm.
TABLE 1
Fluorescence Q for 12AO or MG12AO in LFABP or in EPC SUVs
The Q for 12AO and MG12AO was determined relative to quinine sulfate in 0.1 N
sulfuric acid. 4mM ligands were incubatedwith 80mMLFABP at room temperature
for at least 10min. 10mM ligands were incubated with 200mM EPC SUVs at room




12AO 0.466 0.09 0.516 0.14
MG12AO 0.486 0.17 0.216 0.05 FIGURE 7. MG12AO and 12AO transfer from LFABP versus SUVs. A, the
transfer of MG12AO and 12AO from LFABP to SUVs was measured at 24 °C at
pH 7.4 as described under “Experimental Procedures.” Each time course was
normalized to maximum fluorescence intensity. Final concentrations were 1
mMprobewith 6mMLFABPand0.36mM10%NBD-PE, 90%EPCacceptor SUVs.
B, the transfer of MG12AO and 12AO from SUV to SUV. Conditions were as
described in Fig. 3A. Final concentrationswere 5mMprobewith 0.1mMdonor
EPC SUVs and 0.5 mM 10% NBD-PE, 90% EPC acceptor SUVs. Data shown are
from one of eight representative experiments.
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transfer from LFABP to membranes. The results are shown as
Arrhenius plots in Fig. 10. The activation energy (Ea), enthalpy
(DH‡), entropy (DS‡), andGibbs free energy (DG‡) for the trans-
fer process at 25 °C were estimated using the Eyring rate theory
(42) and are presented in Table 2. The results show that the free
energies of transfer of both 12AO and MG12AO from LFABP
to EPC SUVs are very similar and are composed of a decrease in
entropy as well as a large enthalpic component, both typical of
the aqueous solvation of hydrophobic compounds.
Transfer of 12AO and MG12AO from LFABP to EPC SUVs
was further examined as a function of pH. As described previ-
ously, the rate of 12AO transfer from LFABP to membranes
increased 3–5-fold as pH increased, suggesting that ionization
of the FA carboxyl group is an important determinant of the
transfer process (40, 43). In contrast, the relative lack of effect of
pH on MG12AO transfer rates from LFABP (Fig. 11) presum-
ably reflects the absence of an ionizable functional group in
MG12AO.
FIGURE 8. Effect of acceptor vesicle concentration on 12AO (A) or
MG12AO (B) transfer fromLFABP. Transfer of 12AO (A) orMG12AO (B) from
LFABP to acceptor EPC SUVs was monitored at 24 °C as described in Fig. 6.
Results are means6 S.D. (error bars) from five separate experiments.
FIGURE9.Effect of ionic strengthonMG12AOtransfer rate fromLFABP to
EPC SUVs. The transfer rates and conditions, except for ionic strength, were
determined as described in Fig. 6. Results are means6 S.D. (error bars) from
five separate experiments.
FIGURE 10. Effect of temperature on 12AO or MG12AO transfer from
LFABP to SUVs. Arrhenius plots of 12AO (E) and MG12AO (Œ) transfer from
LFABP to EPC SUVs are shown. Conditions, except for temperature, were as
described in Fig. 6. Results are means 6 S.D. (error bars) from five separate
experiments.
TABLE 2
Thermodynamic parameters for the transfer of MG12AO and 12AO
from LFABP to SUVs
From the rate constants over a temperature range of 15–40 °C, the activation energy
was obtained. DG‡, DH‡, and DS‡ of the activated state were estimated at 25 °C as
described in the text. Results are in kcal/mol and aremeans6 S.D. from five separate
experiments.
Ea DH‡ TDS‡ DG‡
12AO 15.26 2.3 14.66 2.3 24.96 2.4 19.66 0.2
MG12AO 20.26 1.8 19.66 1.8 20.36 1.8 19.86 0.3
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Werecently showed that intestinalmonoacylglycerolmetab-
olism was perturbed in the LFABP-null mouse with less MG
incorporated into TG and more used for phospholipid biosyn-
thesis. Because no concomitant changes in the expression of
relevant lipid synthesis genes were found, we hypothesized that
LFABP plays a role in trafficking of MG toward sites of TG
synthesis (14). Nevertheless, there are conflicting reports of
monoacylglycerol binding by LFABP (15, 16). Thus, we under-
took to determine whether LFABP would bind monoacylglyc-
erol in a physiological context by comparing MG binding in
cytosol prepared fromwild type and LFABP2/2mouse liver. As
demonstrated by Martin et al. (22), we confirmed that labeled
fatty acid binding in wild type liver cytosol comprises of two
distinct compartments: a high molecular mass region at ;66
kDa and a low molecular mass region at ;14 kDa. Because in
the present experiments we first perfused the livers to remove
blood, the remaining albuminwas likely at low levels; therefore,
the higher molecular weight peak was not substantial. Immu-
noblotting showed the presence of LFABP in the lowmolecular
mass ;14-kDa fractions, confirming that LFABP is binding
fatty acids in liver cytosol (22). Notably, identical results were
obtained using radiolabeled MG with the 14-kDa protein-con-
taining fractions from WT but not LFABP2/2 liver cytosol
retaining the [3H]monoolein. These results provide strong evi-
dence not only that LFABP does in fact bindMGbut also that it
does so in vivo and is likely to be the major intracellular mono-
acylglycerol-binding protein in the liver, intestine, and perhaps
kidney where LFABP is also expressed.
In contrast to the stoichiometric binding of FA by other
FABPs, LFABP binds two FAs (38, 43, 44). Furthermore,
whereas other members of the FABP family appear to display
high affinity binding only for long chain FAs, LFABP has been
shown to bind a number of other small hydrophobic ligands
including lysophospholipids (45), heme (46), and bile salts (15,
47). Equilibrium binding analysis using the Lipidex assay indi-
cates that the LFABP binding affinities for FA and MG are in a
similar range albeit with MG binding affinity ;2-fold lower
than FA binding affinity. Previously, we reported the solution
structure of rat liver LFABP, confirming the 2:1 FA:protein stoi-
chiometry and demonstrating for the first time the structural
differences in the apo and holo forms of the protein (18). In the
present studies, we provide evidence indicating that the solu-
tion structure of LFABP with bound monoolein resembles that
of the FA-liganded protein with 2 molecules of MG likely to
bind in similar positions to the two FA molecules. A definitive
structural determination of the MG-protein complex would
require intermolecular distance constraints in addition to
chemical shift perturbations (48), but the concordance of MG-
and OA-affected residues is explained most straightforwardly
by similarity of their respective protein-ligand three-dimen-
sional structures.
It is notable that many sites are affected principally either at
the early titration stages (0.6–0.8 eq of MG) or else later (1.0–
1.2 eq of MG). The location and stepwise pattern of these per-
turbations parallel our prior investigations of the OA-LFABP
binding process in which the first ligand was found to bind
deeply within the cavity and the second ligand subsequently
bound closer to the aqueous interface (18). However, the fact
that most of the perturbed backbone sites exhibit protein het-
eronuclear single quantum correlation resonances in interme-
diate exchange (k ; Dd) during the MG-LFABP titration sug-
gests that apo-single-holo exchange is more facile than in the
case of the slowly exchanging OA-FABP, arguing for weaker
LFABP interactions with the monoglyceride ligand in keeping
with the equilibrium binding analysis.
Having established clearly the binding of MG by LFABP in
vivo and in vitro, we sought to investigatewhether LFABP could
serve as an intracellular transport protein for MG. Thus, we
determined the rate and mechanism of MG transfer from
LFABP to membranes in comparison with results for FA trans-
fer and further compared MG transfer from LFABP with MG
transfer from membranes. These studies used an AO-labeled
monoolein (MG12AO) and the equivalent AO-labeled oleic
acid (12AO), both of whichwe have used previously to examine
FA andMGtransfer fromFABPs,membranes, andmicelles (20,
34, 40).
In agreement with our previous results, the transfer rate of
the fatty acid analog 12AO from LFABP to membranes
increased 3–5-fold as pH increased, suggesting that ionization
of the FA carboxyl group is an important determinant of the
transfer process (40, 43). In contrast, the relative lack of effect of
pH on the monoacylglycerol analog MG12AO transfer rates
from LFABP presumably reflects the absence of an ionizable
functional group on MG12AO. The similar blue-shifted emis-
sion maxima for MG12AO and 12AO in LFABP suggest a sim-
ilar degree of steric hindrance of the AO fluorophore in the
binding site, and the similar fluorescence quantum yields for
MG12AO and 12AO bound to LFABP indicate that both lipid
probes experience similar noncovalent interactions in a simi-
FIGURE 11. Effect of pH on 12AO (E) and MG12AO (Œ) transfer rate from
LFABP to SUVs. Concentrated EPC SUVs and LFABP were diluted into ace-
tate-buffered saline at pH 5 or Tris-buffered saline from pH 6 to 9 prior to
assay. Transfer was measured as described in Fig. 6. Results are means6 S.D.
(error bars) from five separate experiments.
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larly hydrophobic environment upon binding to LFABP. Thus,
it is likely that MG binds to LFABP with the glycerol moiety
near the protein surface in some degree of contact with the
aqueous phase and as supported by the location of the NMR
chemical shift perturbations. These binding properties may
reflect the ability of LFABP to bind other ligands with bulky
head groups, such as lysophosphatidylcholine, as well (45).
The present studies clearly demonstrate that the mechanism
of MG12AO transfer from LFABP to SUVs involves aqueous
diffusion of the lipid from protein tomembrane. Upon increas-
ing the concentration of acceptor membrane, no increase in
the transfer rate of MG12AO was observed. This invariance of
transfer rate to acceptor is a hallmark of an aqueous diffusion
transfer mechanism for hydrophobic compounds (49, 50). We
also found that increasing the NaCl concentration of the buffer
reduced the rate ofMG12AO transfer from LFABP logarithmi-
cally, suggesting that the solvation properties of the surround-
ing aqueous phase regulate the movement of MG from LFABP
to membranes. The thermodynamic potentials describing the
transfer process were similar for MG12AO and 12AO with
nearly identical DG values, suggesting that a similar activated
state is formed in the transfer of FA andMG fromLFABP to the
aqueous phase. Therefore, as found previously for FA, the rate-
limiting step in the transfer process is likely the dissociation of
MG12AO from the donor LFABP into the aqueous phase.
In the absorptive enterocyte, both MG and FA are metabo-
lized in the endoplasmic reticulum with subsequent formation
of TG. Large quantities of both metabolites must therefore be
transported from their sites of entry across the plasma mem-
brane to their subcellular sites of metabolic utilization. In
agreement with our previous report (20), the spontaneous
movement of theMG frommembrane to membrane is consid-
erably slower than that of the unesterified fatty acid. In distinct
contrast, the present results show that transfer of FA and MG
derivatives from LFABP tomembranes occurs at virtually iden-
tical rates. Whereas the absolute transfer rate for 12AO from
SUVs or from LFABP is approximately equivalent, the rate of
MG12AO transfer is 7-fold faster from LFABP to membranes
than from membrane to membrane. It is therefore likely that a
function of LFABP may be to facilitate efficient intracellular
movement of both major dietary lipid hydrolytic products to
their sites of utilization. Although the relative amounts of apo-
and holo-LFABP in the enterocyte are not known, the very high
level of expression of LFABP in the small intestine (51) suggests
it is able to accommodate the binding of FA and MG.
In summary, the present studies demonstrate that LFABP
binds monoacylglycerols in vitro and in vivo. Furthermore, the
results show that the MG transfer rate from LFABP is acceler-
ated markedly relative to transfer frommembranes. Unlike the
slower rate (relative to FA) of MG transfer from membranes,
the rates of transfer from LFABP for both these products of
dietary TG digestion to acceptor membranes were essentially
identical, and transfer of both lipids occurs by an aqueous dif-
fusion mechanism. The similarities in transfer properties are
likely to reflect the similar environments experienced by the
two ligands when bound to LFABP as verified by the NMR
chemical shift perturbation of specific protein sites upon MG
ligation. Thus, the results imply that LFABP contributes to the
efficient utilization of fatty acids and MG in intestinal TG
biosynthesis.
Because LFABP is expressed at high concentrations only in
intestine and liver, it remains to be determinedwhich protein(s)
binds MG in other cell types that also experience high rates of
TG synthesis and lipolysis and may therefore generate signifi-
cant amounts of MG, such as the adipocyte. As noted above,
IFABP was found not to bind MG (16), and we observed no
alterations in intestinal MG metabolism in the IFABP2/2
mouse in contrast to what was observed in the LFABP2/2
mouse (14). To our knowledge, no studies have addressed
whether MG is bound by the adipocyte FABP, FABP4, or other
members of the FABP family of proteins. Interestingly, it was
recently reported that multiple FABPsmay bindN-acylethano-
lamines, in particular the arachidonyl derivative N-arachido-
nylethanolamine which, like 2-arachidonoylglycerol, is an
endocannabinoid (52). Studies that address the binding of MG
in adipose and other tissues are underway.
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